Smith Group Asset Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-90
| Closed | -$5K | – | 308 |
|
|
2021
Q4 | $5K | Hold |
90
| – | – | ﹤0.01% | 342 |
|
|
2021
Q3 | $5K | Hold |
90
| – | – | ﹤0.01% | 347 |
|
|
2021
Q2 | $8K | Hold |
90
| – | – | ﹤0.01% | 311 |
|
|
2021
Q1 | $7K | Sell |
90
-2,490
| -97% | -$194K | ﹤0.01% | 291 |
|
|
2020
Q4 | $235K | Hold |
2,580
| – | – | 0.01% | 172 |
|
|
2020
Q3 | $103K | Buy |
+2,580
| New | +$103K | 0.01% | 196 |
|